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We report a case of lethal hepatorenal insufﬁciency in a 52-year-old man who received successful
simultaneous hepatorenal transplantation from a deceased donor. The patient had undergone live-donor
liver transplantation for type-C hepatitis and liver cirrhosis 11 years before he developed graft liver
dysfunction due to recurrent viral hepatitis and cirrhosis. At that instance, he also developed end-stage renal
dysfunction due to calcineurin inhibitor nephropathy and hepatorenal syndrome. Although he needed
three open hemostases and abundant blood transfusion, he was withdrawn from continuous hemodiaﬁltration
on the 55th day and discharged from the hospital on the 272nd day postoperatively. Simultaneous
hepatorenal transplantation was reported to be associated with more favorable outcomes of graft function,
lower rejection rates, but higher perioperative complication rates compared with liver transplantation alone
in patients on hemodialysis. Particularly, close attention should be paid for hemostasis since patients have a
hemorrhagic tendency until the recovery of graft liver function.
(Hinyokika Kiyo 63 : 313-318, 2017 DOI : 10.14989/ActaUrolJap_63_8_313)









患 者 : 52歳，男性，血液型 O＋
身長 174 cm，体重 103 kg（入院前 7カ月で約 35 kg
の体重増加）
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Fig. 1. Clinical course after simultaneous hepatorenal transplantation. The
patient underwent three emergency explorations for hemostasis within
two weeks after transplantation. Most of the blood derivatives were
transfused within four weeks after transplantation. Thereafter,
platelet count and PT-INR became stable without frequent transfusion.
ミコフェノール酸モフェチルの 2剤を中心に，タクロ













血液検査 : WBC 2,600/μl，Hb 6.1 g/dl，Plt 3.8×
104/μl，PT-INR 1.35，APTT 34.4秒，AST 37 IU/l，
ALT 27 IU/l，γGTP 80 IU/l，Alb 1.7 g/dl，T-Bil 2.5
mg/dl，BUN 85 mg/dl，Cre 4.27 mg/dl，Na 141 mEq/
l，K 5.4 mEq/l，Cl 111 mEq/l，CRP 1.8 mg/dl と汎
血球減少を伴う高度の肝機能障害（Child-Pugh score
10点）に加え，末期腎不全の状態であった．























分であった．総出血量は 27,300 ml で濃厚赤血球
14,280 ml（102 U），凍結血小板 1,300 ml（65 U），新




ドニゾロン 125 mg/day の投与を開始し，手術当日と
4日目にバシリキシマブ 20 mg を投与した．
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Fig. 2. Postoperative course of graft kidney function. Urine output (gray columns) was
decreased and serum creatinine (solid line) was elevated around the 5th week
postoperatively, when blood tacrolimus concentration (dashed line) was elevated.
Since graft biopsy suggested calcineurin inhibitor toxicity and the graft renal
function was recovered by dose-down of tacrolimus administration.








384 U，血小板 725 U，新鮮凍結血漿 246 U の輸血を
要した．
移植腎機能に関しては，術後 3日目から尿量が増加















た．治療開始 2カ月で HCV-RNA の陰性化に伴い肝
酵素も正常化し現在も経過は良好である．
移植腎機能に関しては退院後から術後 3年に至るま
で血清 Cre 1.0 mg/dl 程度でおおむね安定している．
現在，免疫抑制療法はタクロリムス 2 mg/day，ミコ
フェノール酸モフェチル 500 mg/day，プレドニゾロ
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Fig. 3. Transmission electron (A, inlet region magniﬁed in B) and light (C, inlet region magniﬁed in D)
microphotographs of graft kidney obtained on postoperative day 45 showing tubular isometric
vacuolization (arrows) and swollen mitochondria (arrowheads) suggestive of calcineurin inhibitor-induced
injury, which was markedly improved on 1-year (E) and almost disappeared on 3-year (F) biopsy
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Kupffer 細胞で大部分処理されてしまうという説10)
































単独，2,000 vs 1,500 ml，p＝0.0083），集中治療室滞
在期間（ 7 vs 3日，p＜0.001），入院期間（25 vs 12
日，p＜0.0001）などで有意差を認めたとされてい
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